Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?

(2020) Karthik Chandrasekharan et al.   Frontiers in Pharmacology

Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk

(2020) Eugene Han et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Macrophages in metabolic associated fatty liver disease

(2020) Jawaher Alharthi et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) Is Independently Associated with Cardiovascular Risk in a Large Austrian Screening Cohort

(2020) David Niederseer et al.   Journal of Clinical Medicine

The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional study

(2020) Bu-yuan Dong et al.   Lipids in Health and Disease

A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial

(2020) Fardin Moradi et al.   JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY

NASH in Lean Individuals

(2019) Ramy Younes et al.   SEMINARS IN LIVER DISEASE

Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study

(2019) Kuan Ken Lee et al.   Lancet Gastroenterology & Hepatology

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

(2019) Juhani Knuuti et al.   EUROPEAN HEART JOURNAL

NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?

(2019) Daniela Stols-Gonçalves et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal

(2018) Bashu Dev Pardhe et al.   BMC GASTROENTEROLOGY

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science

(2018) Mohammad Shadab Siddiqui et al.   HEPATOLOGY

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

(2018) Scott L. Friedman et al.   HEPATOLOGY

Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease

(2018) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis

(2018) Reza Fadaei et al.   Scientific Reports

Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease

(2018) Donald M. Lloyd-Jones et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study

(2018) Qian WANG et al.   Lipids in Health and Disease

Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis

(2017) Camille Lassale et al.   EUROPEAN HEART JOURNAL

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases

(2017) Nima Motamed et al.   Clinics and Research in Hepatology and Gastroenterology

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

(2016) Vlad Ratziu et al.   GASTROENTEROLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications

(2016) Sven M. Francque et al.   JOURNAL OF HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

(2016) Matthew James Armstrong et al.   LANCET

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

(2016) Amedeo Lonardo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Circulating Markers of Liver Function and Cardiovascular Disease RiskSignificance: Figure.

(2015) Giovanni Targher et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

(2015) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature

(2014) Robert J. Wong et al.   DIGESTIVE DISEASES AND SCIENCES

Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation

(2014) Eung Ju Kim et al.   PLoS One

The global NAFLD epidemic

(2013) Rohit Loomba et al.   Nature Reviews Gastroenterology & Hepatology